ArticleInternational journal of molecular medicine2018

Inhibition of osteoclastogenesis for periprosthetic osteolysis therapy through the suppression of p38 signaling by fraxetin.

Jia-Cheng Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.